Activity Description
As HIV prevention evolves, long-acting injectable PrEP (LAI-PrEP) offers a promising option for individuals who may benefit from alternatives to a daily oral medication. Providing a comprehensive overview of LAI-PrEP, this webinar will focus on identifying eligible populations and comparing the benefits and challenges of using any PrEP option.
Participants will learn strategies to promote equitable access, outreach, and uptake, particularly among priority populations. Highlighting funding and reimbursement opportunities to support sustainable LAI-PrEP integration into HIV prevention programs will also be discussed.
Target Audience
This activity is intended for physicians, pharmacists, registered nurses, PAs, psychologists, social workers and other healthcare providers engaged in the care of patients with HIV.
- Media: Enduring Material
- Release date: 02/10/2026
- Expiration date: 02/10/2027
- Time to Complete: 60 minutes
Educational Objectives
- Identify populations eligible for LAI-PrEP based on current guidelines.
- Compare the benefits and implementation challenges of all PrEP options.
- Identify funding and reimbursement opportunities for integrating LAI-PrEP.
- Describe strategies to promote equitable access, outreach, and uptake of LAI-PrEP.
Accreditation, Credit, and Support
Participants can earn up to 1.0 credits/contact hours (CME, AAPA, ANCC, CPE, ASWB) for completion of this educational material.
HealthHIV is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC).
Physician Continuing Medical Education
HealthHIV designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit™.
Physician Associate Credit Designation Statement
This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 02/10/2027.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.
Continuing Pharmacy Education
Type of Activity: Knowledge
UAN: JA4008396-0000-26-011-H02-P
Social Worker Continuing Education
Social workers completing this course receive 1.0 general continuing education credit.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.
Support Statement
This program has no commercial support.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosures
I. Monet Ouwinga, MD
Program and Medical Director of Title X, CCI Greenway
Prince George’s County, MD
Disclosure: Speaker or member of a speaker’s bureau for Gilead Sciences. This relationship has been mitigated in accordance with Joint Accreditation standards.
Jorian Rivera
Washington, DC
Disclosure: No relevant financial relationships with ineligible companies to disclose.
Disclosure & Conflict of Interest Policy
HealthHIV requires disclosure of all financial relationships from the past 24 months and mitigates all conflicts according to policy and Joint Accreditation standards.
Disclosure of Unlabeled Use
This educational activity may contain discussions of investigational or off-label uses. Refer to official prescribing information for approved indications, contraindications, and warnings.
Disclaimer
The information presented is not intended as a guideline for patient management. Clinicians should evaluate individual patient conditions before applying strategies discussed.
Method of Participation
Learners must complete the entire CE activity, post-test, and evaluation with a score of 80% or higher to receive credit. Certificates will be available on eHealthHIV.org. Contact beth@healthhiv.org with questions.
Pharmacists: Participation will be reported to NABP if e-Profile number and DOB (MM/DD) are provided.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, preparation of editorial content, and distribution of this CE activity. Our activities may contain references to unapproved products or uses in certain jurisdictions.
The materials presented here are used with permission of the authors and/or other sources.
For accreditation-related questions, contact accreditation@healthhiv.org.
For certificate issues, contact beth@healthhiv.org.